Please try another search
Vernalis Limited, a commercial stage pharmaceutical company, engages in the research, development, and commercialization of pharmaceutical products for various medical disorders. The company offers Tuzistra XR for the U.S. prescription cough-cold market; Moxatag, a once-a-day formulation of amoxicillin antibiotic for the treatment of tonsillitis and pharyngitis secondary to streptococcus pyogenes in adults and pediatric patients; and frovatriptan for the acute treatment of migraine. It also holds licensing agreement to develop and commercialize various products focused on the U.S. prescription cough-cold market. Vernalis Limited was formerly known as Vernalis plc. The company was incorporated in 1988 and is headquartered in Cambridge, United Kingdom. Vernalis Limited operates as a subsidiary of Ligand Holdings Uk Ltd
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review